Loading…
InMed Pharmaceuticals Inc. is projected to decline to $1.38 by 2027, a -5% move from its current price of $1.46. INM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.40 | $1.46 | $1.52 | +0.03% |
| Aug 6 | $1.38 | $1.46 | $1.55 | +0.05% |
| Aug 7 | $1.36 | $1.46 | $1.57 | +0.08% |
| Aug 8 | $1.35 | $1.46 | $1.58 | +0.10% |
| Aug 9 | $1.34 | $1.46 | $1.60 | +0.13% |
| Aug 10 | $1.33 | $1.46 | $1.61 | +0.16% |
| Aug 11 | $1.32 | $1.46 | $1.63 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.32 | $1.46 | $1.63 | +0.18% |
| Week 2 | $1.26 | $1.47 | $1.70 | +0.36% |
| Week 3 | $1.22 | $1.47 | $1.76 | +0.54% |
| Week 4 | $1.19 | $1.47 | $1.82 | +0.73% |
| Week 5 | $1.16 | $1.47 | $1.87 | +0.91% |
| Week 6 | $1.14 | $1.48 | $1.91 | +1.09% |
| Week 7 | $1.12 | $1.48 | $1.96 | +1.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InMed Pharmaceuticals Inc. is a clinical stage pharmaceutical company that develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceutical products.
The company was formerly Cannabis Technologies Inc., and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
InMed Pharmaceuticals Inc. (INM) is the asset with a current price of $1.50, a market capitalization of $8.01M, and a rank of 4872. The company operates in the Healthcare sector.
Forecasts show a longer-term price trajectory with the 2026 average price of $1.50, rising to $2.15 in 2029 and to $6.64 by 2050. Returns (ROI) reach 342.7% by 2050, with a bullish sentiment indicated from 2029 onward.
A major floor 57.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
The nearest ceiling, 26.7% above — a clean break opens room to run.
A major ceiling 35.4% above — clearing it would confirm fresh momentum.
Key INM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.59 | Sell | $1.57 | Sell |
| MA 10 | $1.62 | Sell | $1.60 | Sell |
| MA 20 | $1.61 | Sell | $1.59 | Sell |
| MA 50 | $1.59 | Sell | $1.48 | Sell |
| MA 100 | $1.16 | Buy | $1.35 | Buy |
| MA 200 | $1.24 | Buy | $1.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.78 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -142.72 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -7.55 | Sell |
| Bollinger %B (20,2) | 0.07 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.35 | Buy |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 39.60 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 1.53 | Sell |
| ADX (14) | 18.59 | Neutral |
| ATR (14) | 0.06 | Info |
The near-term picture is neutral, with RSI(14) at 40. The price sits near the 50-day simple moving average of $1.59 and above the 200-day simple moving average of $1.24. Support is at $1.49 and resistance at $1.85, framing a 30-day range from $1.14 to $1.97. Annualized volatility is high at 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.615 | $1.46 | $1.96 | 0% | Neutral | |
| $1.06 | $1.38 | $1.94 | -5% | Neutral | |
| $1.19 | $1.63 | $2.41 | +12% | Neutral | |
| $1.49 | $2.12 | $3.26 | +45% | Bullish | |
| $1.40 | $2.05 | $3.25 | +40% | Bullish | |
| $1.41 | $2.14 | $3.49 | +46% | Bullish | |
| $1.42 | $2.20 | $3.69 | +51% | Bullish | |
| $1.26 | $2.00 | $3.44 | +37% | Bullish | |
| $1.25 | $2.04 | $3.57 | +40% | Bullish | |
| $1.40 | $2.35 | $4.20 | +61% | Bullish | |
| $1.57 | $2.96 | $5.73 | +103% | Bullish | |
| $3.03 | $6.73 | $14.61 | +361% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.615 | $1.46 | $1.87 | +0.00% |
| September 2026 | $1.31 | $1.57 | $1.95 | +7.70% |
| October 2026 | $1.23 | $1.49 | $1.88 | -4.93% |
| November 2026 | $1.20 | $1.47 | $1.87 | -1.89% |
| December 2026 | $1.23 | $1.52 | $1.96 | +3.39% |
Click any year to see its month-by-month INM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, INM could reach as high as $1.96, with a base case around $1.46 and support toward $0.615 — roughly 0% from $1.46. A consolidation phase looks the most probable path here.
Expect INM to range from $1.06 to $1.94 through 2027. The $1.38 average target implies a -5% move from current prices. That is -5% versus the projected 2026 average. Price action looks broadly range-bound.
The INM price prediction for 2028 points to an average of $1.63 (low $1.19, high $2.41) — a potential gain of +12% on today's $1.46. A consolidation phase looks the most probable path here.
In 2029, INM is projected to trade between $1.49 and $3.26, averaging $2.12 — a potential gain of +45% from today's $1.46. That is up +30% on the projected 2028 average. Momentum favours further upside here.
InMed Pharmaceuticals Inc.'s 2030 outlook centres on $2.05, within a $1.40 to $3.25 range. That is -3% versus the projected 2029 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, INM could reach as high as $3.49, with a base case around $2.14 and support toward $1.41 — roughly +46% from $1.46. Momentum favours further upside here.
Expect INM to range from $1.42 to $3.69 through 2032. The $2.20 average target implies a +51% move from current prices. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The INM price prediction for 2033 points to an average of $2.00 (low $1.26, high $3.44) — a potential gain of +37% on today's $1.46. Momentum favours further upside here.
In 2034, INM is projected to trade between $1.25 and $3.57, averaging $2.04 — a potential gain of +40% from today's $1.46. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
InMed Pharmaceuticals Inc.'s 2035 outlook centres on $2.35, within a $1.40 to $4.20 range. That is up +15% on the projected 2034 average. That marks a +61% change versus current levels. Momentum favours further upside here.
By 2040, INM could reach as high as $5.73, with a base case around $2.96 and support toward $1.57 — roughly +103% from $1.46. Buyers look set to stay in control over this stretch.
Expect INM to range from $3.03 to $14.61 through 2050. The $6.73 average target implies a +361% move from current prices. That is up +128% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in INM today (≈ 684.931507 INM) could be worth
$4,612.46
+$3,612.46 (+361%) by 2050 · US Dollar
Based on the average projected INM price of $6.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INMwould be worth at today's price.
$1,000 invested in INM on Jul 31, 2025 (≈ 411.522622 INM) would be worth
$600.82
-$399.18 (-39.9%) today · 0.60× · US Dollar
Based on a INM entry price of $2.43 vs. today's $1.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.71 | $853.8 | -14.6% |
| 1 month ago | $1.59 | $918.24 | -8.2% |
| 3 months ago | $0.715 | $2,041.96 | +104.2% |
| 6 months ago | $1.1 | $1,327.27 | +32.7% |
| 1 year ago | $2.43 | $600.82 | -39.9% |
| All time (5.0y) ago | $1,225 | $1.19 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INM forecast.
Our base-case forecast reaches $2.90 around 2040.
Implied market cap at $2.90: $15.48M
Over the multi-year horizon, the forecast shows a transition from neutral to bullish, with the average price rising from $1.50 in 2026 to $6.64 in 2050. The 2029 average is $2.15 and the 2030 average is $2.05, with rising confidence into the 2030s and 2040s. The ROI figures reflect upside potential, with 2029 at 43%, 2030 at 37%, 2031 at 44.4%, 2032 at 48.4%, and 2050 at 342.7%, but outcomes are uncertain and not guaranteed.
Tap a question to reveal the answer.
The forecasted 2030 average price is $2.05, with a minimum of $1.39 and a maximum of $3.29; the implied ROI is 37% and the sentiment is BULLISH.
Forecasts show an average price of $1.50 in 2026, rising to $2.15 in 2029 and to $6.64 in 2050, with a 342.7% ROI in 2050; these are estimates and not guarantees.
Yes, the 2035 maximum forecast is $4.22, while the 2035 average is $2.34; reaching around $4 is within the forecast range but not guaranteed.
Current price is $1.50 and market capitalization is $8.01M.
RSI(14) is 40, with a 50-day SMA of $1.59 and a 200-day SMA of $1.24. The price sits above support at $1.49 and below resistance at $1.85; the 30-day range is $1.14 to $1.97.
InMed Pharmaceuticals Inc. Community Discussion
0Share your InMed Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.